2011
DOI: 10.1002/mc.20763
|View full text |Cite
|
Sign up to set email alerts
|

Methyl‐CpG binding column‐based identification of nine genes hypermethylated in colorectal cancer

Abstract: DNA methylation is an epigenetic event that plays a role in gene expression regulation. Alterations in DNA methylation contribute to cancer development and progression. The aim of this study was to identify gene promoters aberrantly methylated in colorectal tumor tissue in comparison to normal colonic mucosa. Analyses were performed on two pooled DNA samples: from normal and cancerous tissue obtained from CRC patients. DNA was fractionated according to methylation degree with the use of affinity column contain… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
22
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 40 publications
(22 citation statements)
references
References 42 publications
(45 reference statements)
0
22
0
Order By: Relevance
“…The rationale was based on evidence that overexpression of different KLF transcription factors promote or inhibit neurite outgrowth of RGCs and other neurons (7), the role of EPHA5 in patterning RGC axon connectivity during early visual system development (33), and our previous identification of putativeKLF-bindingsitesassociatedwithdifferentialCpGmethylation within the EphA5 promoter in the nasal versus temporal retina (25). DNA hypermethylation is a well known epigenetic mechanism for gene silencing, and hypermethylation of the EPHA5 promoter (Ͼ70%) has been detected in prostate (24), colorectal (23), and breast cancers (22) and is highly correlated with transcriptional silencing of EPHA5. We previously showed that EphA5 promoter transactivation in luciferase assays is blocked by SssI methylation of all CpG dinucleotides and that transcription of the endogenous EphA5 gene in a mouse Müller glial cell line is silenced by hypermethylation (25).…”
Section: Regulation Of Epha5 Expression By Klfs and Dna Methylation-tmentioning
confidence: 99%
See 1 more Smart Citation
“…The rationale was based on evidence that overexpression of different KLF transcription factors promote or inhibit neurite outgrowth of RGCs and other neurons (7), the role of EPHA5 in patterning RGC axon connectivity during early visual system development (33), and our previous identification of putativeKLF-bindingsitesassociatedwithdifferentialCpGmethylation within the EphA5 promoter in the nasal versus temporal retina (25). DNA hypermethylation is a well known epigenetic mechanism for gene silencing, and hypermethylation of the EPHA5 promoter (Ͼ70%) has been detected in prostate (24), colorectal (23), and breast cancers (22) and is highly correlated with transcriptional silencing of EPHA5. We previously showed that EphA5 promoter transactivation in luciferase assays is blocked by SssI methylation of all CpG dinucleotides and that transcription of the endogenous EphA5 gene in a mouse Müller glial cell line is silenced by hypermethylation (25).…”
Section: Regulation Of Epha5 Expression By Klfs and Dna Methylation-tmentioning
confidence: 99%
“…There is evidence for silencing of EphA5 expression by hypermethylation in cancer (22)(23)(24). We previously showed that total CpG methylation abolishes activity of mEphA5 promoter-reporter constructs in R28 retinal progenitor cells and that transcriptional silencing of the endogenous EphA5 gene in a mouse retinal cell line (ImM10) is reversed by genome-wide demethylation (25).…”
mentioning
confidence: 99%
“…Here, EPHB1, EPHA5, and EPHA6 were the most frequently mutated Eph receptors, accounting for 63% of Eph mutations. EPHA5 has been associated with metastases in breast cancer, where promoter hypermethylation results in downregulation of expression (39,40). Although EphA6 expression was found strongly downregulated in colorectal cancer compared with normal colon, mutations have not previously been reported in CIN tumors (41).…”
Section: Discussionmentioning
confidence: 97%
“…EphA5 gene silenced by methylation has been demonstrated in breast cancer [14], prostate cancer [20], and colorectal cancer [21], implying that the hypermethylation of EphA5 might be of great importance during tumorigenesis and progression in cancer. Identification of hypermethylated EphA5 DNA in ovarian serous carcinoma will improve our understanding of the mechanisms leading to the downregulation of EphA5 expression in ovarian tumorigenesis and can serve as valuable diagnostic marker.…”
Section: Discussionmentioning
confidence: 99%